We focus on novel drug discovery by generative AI
Founded in 2018, we aim to redefine the paradigm of small molecule drug discovery by combining deep pharmaceutical expertise with breakthroughs in generative AI
Powered by comprehensive and unique data assets, advanced generative modeling, and an industry-oriented evaluation framework, our AI platform, IMOLX, accelerates drug discovery from pocket to drug candidate, empowering researchers to explore vast chemical space and unlock breakthrough innovations.
IMOLX, accelerates the journey of drug discovery from idea to drug candidate
MolVado
MolVortex
Based on our AI platform, we created MolVado™, a ready-to-use solution for CADD specialists and medicinal chemists. By combining a multimodal 3D small molecule generation model with a suite of CADD tools, it accelerates the design of novel, drug-like compounds from pocket to drug candidate.
De Novo generation based on empty pocket
Generation based on fixed fragments of reference molecules
MolVortex® is built on the Microscopic Molecular World Model, it runs on a multi-agent collaborative framework.It autonomously breaks down R&D goals, coordinates all R&D tools, and delivers clear decision-making outcomes.MolVortex connects seamlessly with wet lab processes to form a DMTA closed loop of design, synthesis, testing and iteration. All end-to-end R&D data is structured into evolvable digital R&D assets.
The copilot for next-generation drug discovery
Publications
We employ a combination of accelerated molecular dynamics and machine learning to unravel how the dynamic characteristics of CBL-B and C–CBL confer their binding affinity and selectivity for ligand...
Exclusively prioritizing the precision of energy prediction frequently proves inadequate in satisfying multifaceted requirements. A heightened focus is warranted on assessing the rationality of pot...
Vesicular monoamine transporter 2 (VMAT2) accumulates monoamines in presynaptic vesicles for storage and exocytotic release, and has a vital role in monoaminergic neurotransmission1,2,3. Dysfunctio...
Chemical reactions are the fundamental building blocks of drug design and organic chemistry research. In recent years, there has been a growing need for a large-scale deep-learning framework that c...
White Paper
A New Paradigm for AI-Driven 3D Molecular Design Integrating Experimental Electron Density and Language Models
Using Generative Al to Redefine the Paradigm for Drug Discovery
Follow Us
Address: 7 temasek boulevard,#12-07 suntec tower 1, singapore 038987
BD Inquiries: bd@imolx.com
Technical Support: support@imolx.com
Media Inquiries: press@imolx.com
General Inquiries: info@imolx.com